Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Schneck

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 11, 2006
Contrast echocardiography: experience in a clinical echocardiography laboratorySteven J Lester, John W Askew, R Todd Hurst, et al.
Journal of Medicinal Chemistry|February 29, 2020
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen PresentationJohn Liddle, Jonathan P Hutchinson, Semra Kitchen, et al.
Nature|January 21, 2026
Identification of an allosteric site on the E3 ligase adapter cereblonVanessa N Dippon, Zeba Rizvi, Anthony E Choudhry, et al.
Cancer & Metabolism|November 28, 2013
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsJulia Billiard, Jennifer B Dennison, Jacques Briand, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacementLinda S Barton, James F Callahan, Juan Cantizani, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Cancer Cell|July 16, 2015
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P Mohammad, Kimberly N Smitheman, Chandrashekhar D Kamat, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 11, 2006
Contrast echocardiography: experience in a clinical echocardiography laboratorySteven J Lester, John W Askew, R Todd Hurst, et al.
Journal of Medicinal Chemistry|February 29, 2020
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen PresentationJohn Liddle, Jonathan P Hutchinson, Semra Kitchen, et al.
Nature|January 21, 2026
Identification of an allosteric site on the E3 ligase adapter cereblonVanessa N Dippon, Zeba Rizvi, Anthony E Choudhry, et al.
Cancer & Metabolism|November 28, 2013
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsJulia Billiard, Jennifer B Dennison, Jacques Briand, et al.
Bioorganic & Medicinal Chemistry|February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacementLinda S Barton, James F Callahan, Juan Cantizani, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Cancer Cell|July 16, 2015
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P Mohammad, Kimberly N Smitheman, Chandrashekhar D Kamat, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Pageof 10